Single intravitreal injection of axitinib hydrogel implant followed by a mock (sham) injection procedure at Week 24

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.